Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
December 8, 2023
The relationship between statin administration timing and survival outcomes in patients with cancer receiving immune checkpoint blockade
Zihan Wang, Xin Ya See, Cho-Hung Chiang, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
January 21, 2025
Cardiovascular and thromboembolic outcomes with immune checkpoint inhibitors in gastroesophageal cancer: a propensity score-matched cohort study
Furkan Bahar, Betul Ibis, Sena Cakir Colak, et al.
Thrombosis Research
|
August 21, 2024
The association between pembrolizumab and risk of venous thromboembolism in patients with breast cancer
Cho-Han Chiang, Xiaocao Xu, Junmin Song, et al.
Journal of Thrombosis and Thrombolysis
|
April 1, 2025
Khorana risk score in lung cancer patients treated with immune checkpoint inhibitors: a real-world study
Junmin Song, Ahmed Ashraf Morgan, Ana Maria Diaz Abram, et al.
Heart (British Cardiac Society)
|
April 5, 2020
Safety and efficacy of the European Society of Cardiology 0/1-hour algorithm for diagnosis of myocardial infarction: systematic review and meta-analysis
Cho-Han Chiang, Cho-Hung Chiang, Gin Hoong Lee, et al.
European Journal of Preventive Cardiology
|
August 17, 2024
Impact of Sodium-glucose cotransporter-2 inhibitors on Cardiovascular Outcomes of Prostate Cancer Patients Receiving Gonadotropin-Releasing Hormone Agonists
Zhiting Tang, Yu-Cheng Chang, Kuan-Yu Chi, et al.
Immunotherapy
|
May 8, 2025
Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapy
Junmin Song, Ahmed Ashraf Morgan, Jaeun Ahn, et al.
Journal of the American Academy of Dermatology
|
March 1, 2025
Cytotoxic T-lymphocyte associated protein 4 inhibitors are associated with a higher risk of cardiovascular events than programmed cell death protein 1 inhibitors in patients with melanoma
Ching-Chung Chang, Shao-Wei Lo, Hua-Ching Chang, et al.
Journal of Personalized Medicine
|
June 25, 2026
Classic Hairy Cell Leukemia and Related Disorders: An Updated Review of Molecular Features and Personalized Therapies
Pratik Vijay Shah, Anita Ng, Andrew Shih, et al.
Journal of Thrombosis and Thrombolysis
|
April 26, 2024
Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysis
Cho-Han Chiang, Omer Ahmed, Weitao Liu, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Journal of Chemotherapy (Florence, Italy)
|
December 8, 2023
The relationship between statin administration timing and survival outcomes in patients with cancer receiving immune checkpoint blockade
Zihan Wang, Xin Ya See, Cho-Hung Chiang, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
January 21, 2025
Cardiovascular and thromboembolic outcomes with immune checkpoint inhibitors in gastroesophageal cancer: a propensity score-matched cohort study
Furkan Bahar, Betul Ibis, Sena Cakir Colak, et al.
Thrombosis Research
|
August 21, 2024
The association between pembrolizumab and risk of venous thromboembolism in patients with breast cancer
Cho-Han Chiang, Xiaocao Xu, Junmin Song, et al.
Journal of Thrombosis and Thrombolysis
|
April 1, 2025
Khorana risk score in lung cancer patients treated with immune checkpoint inhibitors: a real-world study
Junmin Song, Ahmed Ashraf Morgan, Ana Maria Diaz Abram, et al.
Heart (British Cardiac Society)
|
April 5, 2020
Safety and efficacy of the European Society of Cardiology 0/1-hour algorithm for diagnosis of myocardial infarction: systematic review and meta-analysis
Cho-Han Chiang, Cho-Hung Chiang, Gin Hoong Lee, et al.
European Journal of Preventive Cardiology
|
August 17, 2024
Impact of Sodium-glucose cotransporter-2 inhibitors on Cardiovascular Outcomes of Prostate Cancer Patients Receiving Gonadotropin-Releasing Hormone Agonists
Zhiting Tang, Yu-Cheng Chang, Kuan-Yu Chi, et al.
Immunotherapy
|
May 8, 2025
Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapy
Junmin Song, Ahmed Ashraf Morgan, Jaeun Ahn, et al.
Journal of the American Academy of Dermatology
|
March 1, 2025
Cytotoxic T-lymphocyte associated protein 4 inhibitors are associated with a higher risk of cardiovascular events than programmed cell death protein 1 inhibitors in patients with melanoma
Ching-Chung Chang, Shao-Wei Lo, Hua-Ching Chang, et al.
Journal of Personalized Medicine
|
June 25, 2026
Classic Hairy Cell Leukemia and Related Disorders: An Updated Review of Molecular Features and Personalized Therapies
Pratik Vijay Shah, Anita Ng, Andrew Shih, et al.
Journal of Thrombosis and Thrombolysis
|
April 26, 2024
Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysis
Cho-Han Chiang, Omer Ahmed, Weitao Liu, et al.
Page
of 8